NDRA - エンドラ・ライフ・サイエンシズ (ENDRA Life Sciences Inc.)

NDRAのニュース

   As The Stock Falls By -58.51% Year-To-Date, ENDRA Life Sciences Inc. (NASDAQ: NDRA)’S Stock Continues To Progress In 2022  2022/08/27 12:30:00 Marketing Sentinel
During the last session, ENDRA Life Sciences Inc. (NASDAQ:NDRA)’s traded shares were 0.4 million, with the beta value of the company hitting 1.37. At the end of the trading day, the stock’s price was $0.29, reflecting an intraday loss of -5.09% or -$0.01. The 52-week high for the NDRA share is $2.09, that puts it … As The Stock Falls By -58.51% Year-To-Date, ENDRA Life Sciences Inc. (NASDAQ: NDRA)’S Stock Continues To Progress In 2022 Read More »
   ENDRA Life Sciences receives European patent for TAEUS system  2022/08/24 13:17:32 Seeking Alpha
ENDRA Life Sciences (NDRA) said on Wednesday the European Patent Office had issued Patent for its TAEUS system to calculate fat concentration in the human body with multiple…
   ENDRA Life Sciences Announces Issuance of 8th European Patent for its TAEUS® System  2022/08/24 12:40:00 Business Wire
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of imaging technologies and Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the European Patent Office has issued European Patent No. 3730041 (the ‘041 patent) to ENDRA titled “System for Estimating Fractional Fat Content of an Object.” The ‘041 patent protects ENDRA''s TAEUS system for the calculation of fat concentration in the human body with multiple thermoacoustic measurements. The ‘041 patent
   ENDRA Life Sciences Announces Issuance of 8th European Patent for its TAEUS System  2022/08/24 12:40:00 Wallstreet:Online
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of imaging technologies and Thermo Acoustic Enhanced UltraSound (TAEUS), announces that the European Patent Office has issued European Patent No. 3730041 (the ‘041 patent) to ENDRA titled “System for Estimating Fractional Fat Content of an Object.” The ‘041 patent protects ENDRA''s TAEUS system for the calculation of fat concentration in
   ENDRA Life Sciences: Q2 Earnings Insights  2022/08/16 03:19:58 Benzinga
ENDRA Life Sciences (NASDAQ: NDRA ) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM. Here''s what investors need to know about the announcement. Earnings ENDRA Life Sciences missed estimated earnings by 20.0%, … Full story available on Benzinga.com
   ENDRA Life Sciences rises on new U.S. patent for liver disease monitoring system  2022/06/28 12:45:09 Seeking Alpha
ENDRA Life Sciences (NDRA) is trading 10% higher premarket after the United States Patent and Trademark Office issued a new patent for its Taeus’ radiofrequency ((RF)) applicator…
   ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of 28th U.S. Patent  2022/06/28 12:00:00 Business Wire
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NAFLD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the United States Patent and Trademark Office has issued a new ENDRA patent, U.S. Patent No. 11369272 (the ‘272 patent) titled “Broadband Applicator for Thermoacoustic Signal Generation.” The ‘272 patent protects TAEUS’ radiofrequency (RF) applicator for optimizing the delivery of RF energy to tissue. Notably, the RF applicator utilizes a broad ba
   ENDRA Life Sciences Enhances TAEUS System Intellectual Property Portfolio with Issuance of 28th U.S. Patent  2022/06/28 12:00:00 Wallstreet:Online
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS), announces that the United States Patent and Trademark Office has issued a new ENDRA patent, U.S. Patent No. 11369272 (the ‘272 patent) titled “Broadband Applicator for Thermoacoustic Signal Generation.” The ‘272 patent protects TAEUS’ radiofrequency (RF) applicator for optimizing the delivery
   ENDRA Life Sciences to Participate in the JMP Securities Life Sciences Conference  2022/06/08 12:00:00 Business Wire
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NAFLD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that management will be participating in the JMP Securities Life Sciences Conference being held June 15-16, 2022 in New York City. Management will present a company overview on Wednesday, June 15th at 2:30 p.m. Eastern time and will host one-on-one meetings with investors. To request a meeting, please contact JMP Securities or Yvonne Briggs of LHA at ybriggs
   Investment - Zacks: Analysts Expect ENDRA Life Sciences Inc. Will Post Earnings of -$0.05 Per Share  2022/06/04 10:07:26 Business Mag
Equities analysts predict that ENDRA Life Sciences Inc. will announce earnings per share of for the current fiscal quarter, Zacks Investment Research reports. Zero analysts…
   ENDRA Life Sciences to Report First Quarter 2022 Financial Results on May 12, 2022  2022/05/02 12:00:00 Business Wire
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NAFLD--ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results for the first quarter of 2022 on Thursday, May 12, 2022 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast beginning at 4:30 p.m. Eastern time to discuss the results, provide an update on recent corporate developments and answer questions. Partici
   ENDRA Life Sciences Inc. (NASDAQ: NDRA) Stock Seems Like A Good Option  2022/04/22 12:00:00 Stocks Register
ENDRA Life Sciences Inc. (NASDAQ:NDRA) shares, rose in value on Thursday, April 21, with the stock price up by 1.59% to the previous day’s close as strong demand from buyers drove the stock to $0.27. Actively observing the price movement in the last trading, the stock closed the session at $0.26, falling within a range … ENDRA Life Sciences Inc. (NASDAQ: NDRA) Stock Seems Like A Good Option Read More »
   Endra Life Sciences raises $8.7M YTD from common stock sale through ATM equity facility  2022/04/21 13:08:17 Seeking Alpha
Endra Life Sciences raised $8.7M year-to-date from the sale of common stock through its at the market, or ATM, equity facility.
   Thinking about buying stock in ENDRA Life Sciences, SeaChange, Protalix Biotherapeutics, Dingdong, or BigBear.ai?  2022/04/08 13:31:00 Benzinga
NEW YORK , April 8, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NDRA, SEAC, PLX, DDL, and BBAI. … Full story available on Benzinga.com
   16 Stocks Moving in Friday''s Pre-Market Session  2022/04/08 11:11:38 Benzinga
Gainers Biofrontera Inc. (NASDAQ: BFRI ) rose 34.5% to $5.44 in pre-market trading. ENDRA Life Sciences Inc. (NASDAQ: NDRA ) rose 31.9% to $0.5891 in pre-market trading after gaining over 10% on Thursday. HC Wainwright & Co. maintained ENDRA Life Sciences with a Buy and lowered the price target from $6 to $5. MedAvail Holdings, Inc. (NASDAQ: MDVL ) rose 29.1% to $1.82 in pre-market trading. MedAvail shares jumped 64% on Thursday after Ally Bridge Group reported in a Form4 filing a purchase of roughly 21.176 million shares of MedAvail Holdings for an average price of $1.06 per share. Sunshine Biopharma, Inc. (NASDAQ: SBFM ) shares rose 20.7% to $11.65 in pre-market trading after surging 53% on Thursday. Aterian, Inc. (NASDAQ: … Full story available on Benzinga.com

calendar